Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a01d7935508cbe002beb151d4efde669 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate |
2006-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d63bdd5b7ac3fb8f762cb35bbd7ff88 |
publicationDate |
2007-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1846578-A2 |
titleOfInvention |
Methods of identifying genes which modulate myelination |
abstract |
The present invention relates to methods of identifying and/or characterizing genes that are modulated during myelination or remyelination, as well as in demyelinating diseases such as in multiple sclerosis. The invention further provides methods of treating diseases related to myelination in a mammal, such as multiple sclerosis, by administering agents that promote remyelination of oligodendrocytes. |
priorityDate |
2005-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |